Li, L., Deng, L., Meng, X., Gu, C., Meng, L., Li, K., . . . Huang, H. (2020). Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing. Transl Oncol.
Citación estilo ChicagoLi, Li, et al. "Tumor-targeting Anti-EGFR X Anti-PD1 Bispecific Antibody Inhibits EGFR-overexpressing Tumor Growth By Combining EGFR Blockade and Immune Activation With Direct Tumor Cell Killing." Transl Oncol 2020.
Cita MLALi, Li, et al. "Tumor-targeting Anti-EGFR X Anti-PD1 Bispecific Antibody Inhibits EGFR-overexpressing Tumor Growth By Combining EGFR Blockade and Immune Activation With Direct Tumor Cell Killing." Transl Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.